Related Experiment Video
Updated: Mar 8, 2026

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry
Published on: November 21, 2025
Histone demethylases and their roles in cancer epigenetics
Alexandra D'Oto1, Qing-Wu Tian2, Andrew M Davidoff1
1Department of Surgery, St Jude Children's Research Hospital, Memphis, USA.
Abstract:
The genetic abnormalities that drive tumorigenesis are usually coupled with epigenetic alterations, such as DNA methylation and aberrant histone modifications, which may help oncogenic drivers accelerate cancer progression, metastasis, and therapy resistance. The discovery of histone demethylases has provided us new insight for understanding the epigenetic landscape of the chromatin environment of cancer cells. This review aims to summarize the current knowledge on the human histone lysine demethylases and their functions in cancers, and recent advances in development of small molecule inhibitors to target histone demethylases in cancer treatment.
Insights
Cancer progression is linked to epigenetic changes like DNA methylation. This review covers human histone demethylases, their cancer roles, and new small molecule inhibitors for cancer therapy.
Area of Science:
- Molecular Biology
- Epigenetics
- Oncology
Background:
- Tumorigenesis involves genetic abnormalities and epigenetic alterations.
- Histone modifications, including DNA methylation, are crucial in cancer development.
- Histone demethylases are key regulators of the cancer epigenome.
Purpose of the Study:
- To review human histone lysine demethylases and their functions in cancer.
- To summarize recent advances in developing small molecule inhibitors targeting these enzymes for cancer treatment.
Main Methods:
- Literature review of scientific publications.
- Analysis of current knowledge on histone demethylases in cancer.
- Overview of small molecule inhibitor development.
Main Results:
- Histone demethylases play significant roles in cancer progression, metastasis, and therapy resistance.
- Targeting histone demethylases with small molecule inhibitors shows therapeutic potential.
Conclusions:
- Histone demethylases are critical players in cancer epigenetics.
- Inhibitors targeting histone demethylases represent a promising avenue for novel cancer therapies.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Spreading of Chromatin Modifications
Writers
The writer...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Histone Variants at the Centromere

